Leading the way in breast cancer screening and prevention

Journal of General Internal Medicine

Volumn 19, Issue 4, 2004, Pages 390-391

  Armstrong, Katrina ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TAMOXIFEN;

BREAST CANCER; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURGERY; DOCTOR PATIENT RELATION; EDITORIAL; HUMAN; MAMMOGRAPHY; MEDICAL DECISION MAKING; OBESITY; ORGANIZATION; RISK REDUCTION;

EID: 1942531626     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2004.42001.x     Document Type: Editorial

References (14)

1. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten to fourteen year effects of breast cancer screening on mortality. J Natl Cancer Inst. 1982;69:349-55.
2. Kolata G. Stand on mammograms greeted by outrage. New York Times. January 28, 1997:C1.
3. Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med. 2000;342:564-71.
4. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371-88.
5. Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol. 2001;19:3524-31.
6. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338:1089-96.
7. Thomas D, Gao D, Ray R, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst. 2002;94:1445-57.
8. Taback B, Giuliano AE, Hansen NM, Singer FR, Shu S, Hoon DS. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients. Cancer Res. 2003;63:1884-7.
9. Poon EG, Haas JS, Puopolo AL, et al. Communication factors in the follow-up of abnormal mammograms. J Gen Intern Med. 2004;19:316-23.
10. Wee CC, McCarthy EP, Davis RB, Phillips RS. Obesity and breast cancer screening: the influence of race, illness burden, and other factors. J Gen Intern Med. 2004;19:324-31.
11. Haas JS, Kaplan CP, Gregorich SE, Pérez-Stable EJ, Des Jarlais G. Do physicians tailor their recommendations for breast cancer risk reduction based on patient's risk? J Gen Intern Med. 2004;19:302-9.
12. Schwartz LM, Woloshin S, Fowler FJ, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291:71-8.
13. Davids SL, Schapira MM, McAuliffe TL, Nattinger AB. Predictors of pessimistic breast cancer risk perceptions in a primary care population. J Gen Intern Med. 2004;19:310-15.
14. Welch HG. Should 1 Be Tested for Cancer? Maybe Not and Here's Why. The University of California Press: 2004. Available at: http://www.ucpress.edu/ books/pages/10079.html. Accessed January 26, 2004.